Filter By Industry
Filter By Tag

Newsroom

Nadrich and Cohen LLP Press releases

11 - 20 of 34 Press Releases

Mar 02, 2012
Nadrich & Cohen, LLP is now investigating cases of Stevens Johnson Syndrome caused by the prescription drug Lamictal.

Mar 01, 2012
Nadrich & Cohen, LLP reports that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has issued new health guidelines for patients with metal hip implants.

Feb 28, 2012
Nadrich & Cohen, LLP reports on a recent email which suggests that Johnson & Johnson was aware of problems with its DePuy ASR hips for a year before the devices were ever recalled.

Feb 24, 2012
Nadrich & Cohen, LLP is now offering free case reviews to patients who developed Stevens Johnson Syndrome after taking certain medications.

Feb 23, 2012
Nadrich & Cohen, LLP is now offering free initial case evaluations to Dilantin users who suffered side effects after taking the drug.

Feb 17, 2012
Nadrich & Cohen, LLP reports that Johnson & Johnson is defending its withdrawal of a PMA for a rejected metal hip device that was reportedly sold overseas.

Feb 14, 2012
Nadrich & Cohen, LLP reports that the federal judge presiding over the consolidated Actos bladder cancer cases has scheduled the first hearing in the pending litigation.

Feb 12, 2012
Nadrich & Cohen, LLP reports that a new British study suggests that patients with metal hip implants may be at an increased risk for developing cancer.

Feb 08, 2012
A U.S. Judicial Panel has voted to consolidate three vaginal mesh multidistrict litigations into a single proceeding before a West Virginia district judge.

Feb 05, 2012
Nadrich & Cohen, LLP reports that W.R. Grace has offered a $19.5M settlement to Montana residents who suffered asbestos-related complications.


Page: Prev 1 2 3 4 Next
Nadrich and Cohen LLP RSS Feed